Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Facebook Messenger App: Facebook Getting Serious About Voice

Page 1 of 2

Facebook Inc (FB)Facebook Messenger App: Have you enjoyed using Facebook Inc (NASDAQ:FB)’s Messenger app in the past? If so, you are really going to be excited about what the future holds.

In addition to the features you have grown to love for your iOS or Android device, the app is now turning its focus to voice calls and messages.

As reported by Forbes, the company is testing free voice calls via the Messenger app.

Facebook is also testing a new feature that enables free voice calls using the Messenger app–right now this only works in Canada and only on the iOS app. Using this new test, people can tap the “i” in the top right corner of the app and then tapp “Free Call.” This only works with the version of the app released today.

With this latest update, it is easy to see that Facebook Inc (NASDAQ:FB) is truly interested in growing within the mobile communications space.

Rather than leave well enough alone and only allow users to send traditional messages, the company is look into its voice messaging options.

The Forbes article also goes on to explain that this is not the only recent change by the social networking giant:

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!